reference/35864993

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35864993

Outgoing Links

Predicate	Object
contentType	Randomized Controlled Trial\|Journal Article\|Research Support, N.I.H., Extramural
endingPage	463
issn	2274-5807
issueIdentifier	3
pageRange	453-463
publicationName	The Journal of Prevention of Alzheimer's Disease
startingPage	453
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_72f67e999c70893af94c28f79b896159 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_287f30e1fddfb118fc94de1b1cf4025e
bibliographicCitation	Walsh T, Duff L, Riviere ME, Tariot PN, Doak K, Smith M, Borowsky B, Lopez Lopez C, Arratia PC, Liu F, Scholten I, Gordon D, Arbuckle J, Graf A, Quinn M, Ricart J, Langbaum JB. Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer's Prevention Trial: A global Perspective from the API Generation Program. J Prev Alzheimers Dis. 2023;10(3):453–63. PMID: 37357285; PMCID: PMC10426731.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe9881d5f307525742eb7f243a3b6231 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9262381ad9f3209082e20c43d2c1a63 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7dee49d52a43d4bd846a9df327bae45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f30d8a820644c42fb75e11edd91ab5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13e545dcf2392b5bc5e0095c93d8db91 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70e99e692775441ea7e09ff8f6dd4489 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83003a06ecddcb00b42750df93639170 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4470e9737ec817f5b276e3288ca9a74d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f0258ccb50f843bc214ff7fd48c87cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9463504536bb5c1e011549cd1fdcd5f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cb48216af4823d624934ce4b9b75e63 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93d356912dcaaed068a78769d883e70a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f97bb1510346aa3bfa8a61b1ef7a0433 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e839596b299784f8a7db726f27a8cdd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c6b0f09d9cdbaf6b8888f168ea70fd9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67b14d641326bcebc5920369067eb06f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4429438372bcffc51b8fb02baf845a83
date	2023
identifier	https://doi.org/10.14283/jpad.2023.27 https://pubmed.ncbi.nlm.nih.gov/37357285 https://pubmed.ncbi.nlm.nih.gov/PMC10426731
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42950 https://portal.issn.org/resource/ISSN/2274-5807
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer’s Prevention Trial: A global Perspective from the API Generation Program
discusses	http://id.nlm.nih.gov/mesh/M0108562
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88602735 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91873732 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247839 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4043 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70718 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44483291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24883630 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57469731

Total number of triples: 49.